Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $44
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Nathan Treybeck has maintained an Overweight rating on PROCEPT BioRobotics (NASDAQ:PRCT) and increased the price target from $40 to $44.
December 13, 2023 | 3:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Nathan Treybeck maintains an Overweight rating on PROCEPT BioRobotics and raises the price target from $40 to $44, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Nathan Treybeck suggests a bullish outlook on PROCEPT BioRobotics, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100